Projects per year
Phase 1b Open-label, Dose-Identification Study of XPro1595 in Patients with Mild to Moderate Alzheimer's Disease with Elevated high sensitivity C-reactive protein in Blood.
25/09/19 → 31/08/22
VESPUR: Very Early Start to Personalised Upper limb Rehabilitation (VESPUR) after stroke: A Phase II trial of feasibility and safety
5/03/18 → 10/01/21